Therapeutic Hepatitis B Adenovirus
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 8, 2018 (NCT04168333)
Timeline
Indications
Studied for
Mechanism of action
- Hepatitis B virusImmunity, active
Hepatitis B virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04189276 | Phase 2 | Dec 31, 2019 | Tasly Pharmaceuticals, Inc. |
| NCT04168333 | Phase 1 | Jan 8, 2018 | Tasly Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tasly Pharmaceuticals, Inc. | For profit | 2 | 2 | 2 | 2018 |
1 organizations
Page 1 / 1